Notification of Transactions of Directors and Persons Discharging Managerial Responsibility
In accordance with Disclosure and Transparency Rule 3.1.2.(R), Treatt was notified on 13 and 14 May that the following Directors and Persons Discharging Managerial Responsibility had purchased Ordinary shares in the Company, as detailed below:
Director or PDMR
Position
Price Paid Per Share
Number of Shares
Acquired
Holding Following Notification
% Holding of Issued Share Capital
Name in which shares registered
Daemmon Reeve
CEO
437p
4,959
13,856
0.132%
Caroline Reeve
Richard Hope
Group Finance Director
480p
3,996
15,820
0.151%
Alliance Trust Savings Nominees Ltd
Tim Jones
Chairman
425p
1,179
12,499
0.119%
Alpha Trustees Ltd
Douglas Rash
VP Global Sales - Treatt USA
465p
3,500
3,500
0.033%
Charles Schwab & Co Inc
With the exception of the purchase made by Richard Hope, which took place on 14 May, all purchases were made on 13 May.
Contact details
Anita Steer
Company Secretary
++ 44 1284 770028
END
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.